
Kalayani Drugs Private Limited
Founded in 2017 and headquartered in Maharashtra, India.
Founded in 2017 and headquartered in Maharashtra, India.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U36990MH2017PTC298532
298532
Private Limited Indian Non-Government Company
11 Aug 2017
-
-
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Udai Singh ![]() | Director | 11-Aug-2017 | Current |
Anuradha Hedge ![]() | Director | 11-Aug-2017 | Current |
Sangharsh Singh ![]() | Additional Director | 25-Mar-2018 | Current |
Enhance accessibility to Kalayani Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Kalayani Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Udai Singh is a mutual person
Udai Singh is a mutual person
Udai Singh is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kalayani Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kalayani Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalayani Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sangharsh Singh was appointed as a Additional Director was appointed as a Additional Director on 25 Mar 2018 & has been associated with this company since 7 years 1 month .
Udai Bhanu Singh was appointed as a Director was appointed as a Director on 11 Aug 2017 & has been associated with this company since 7 years 8 months .
Anuradha Krishna Hedge was appointed as a Director was appointed as a Director on 11 Aug 2017 & has been associated with this company since 7 years 8 months .
Kalayani Drugs Private Limited was registered on 11 Aug 2017 with Roc Mumbai & aged 7 years 8 months as per MCA records.
Kalayani Drugs Private Limited was incorporated on 11 Aug 2017.
The authorized share capital of Kalayani Drugs Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Kalayani Drugs Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Kalayani Drugs Private Limited is 201 Wood Row Plot -19 Shah Industrial Estate Veera Desai Road, Andheri - West India, Mumbai, Maharashtra, 400053.
The corporate identification number (CIN) of Kalayani Drugs Private Limited is U36990MH2017PTC298532 and the company number is 298532 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.